)
Visual
test
Entera Bio
Entera Bio (ENTX) investor relations material
Entera Bio Corporate presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate presentation summary11 Mar, 2026
Mission and strategy
Focuses on developing transformative, first-in-class oral peptide treatments for underserved therapeutic areas, aiming to drive value for patients, clinicians, and healthcare systems while fostering innovation and resilience.
Technology and platform
Utilizes proprietary N-Tab® technology to enable oral delivery of large, hydrophilic peptide drugs by inhibiting GI enzymatic degradation and enhancing membrane permeability.
Platform supports robust protein design and modification, with partnerships such as OPKO expanding development capabilities.
Lead asset: EB613 for osteoporosis
EB613 is the first once-daily oral PTH (1-34) anabolic tablet for osteoporosis, targeting a $4–6B+ US market with a significant treatment gap, especially among postmenopausal women.
Phase 2 trials met primary and secondary endpoints, showing significant BMD increases at lumbar spine, femoral neck, and total hip, with a safety profile consistent with PTH agonists.
Demonstrated comparable or superior efficacy to Forteo® injections, with strong adoption potential across specialties.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Entera Bio
- EB613, an oral osteoporosis therapy, nears phase three as regulatory changes may expedite approval.ENTX
Oppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual) 202524 Dec 2025 - Up to $100M in securities registered to fund oral peptide therapy, with at-the-market sales via Leerink Partners.ENTXRegistration Filing16 Dec 2025
- EB613 phase three osteoporosis trial to start H1 2026, driving platform innovation.ENTXEvercore ISI 8th Annual HealthCONx Conference3 Dec 2025
- Shareholders will vote on director election, executive pay, policy amendments, and auditor appointment.ENTXProxy Filing2 Dec 2025
- Key votes on director elections, compensation, equity plan, and auditor appointment recommended for approval.ENTXProxy Filing2 Dec 2025
- Shareholders will vote on director election, executive pay increases, and auditor reappointment.ENTXProxy Filing2 Dec 2025
- Votes sought on director, executive pay, and auditor appointment for 2025.ENTXProxy Filing2 Dec 2025
- Director elections, compensation changes, equity plan amendment, and auditor ratification on agenda.ENTXProxy Filing2 Dec 2025
- Net loss was $3.2M in Q3 2025; FDA endorsed BMD endpoint and cash runway extends to Q3 2026.ENTXQ3 202514 Nov 2025
Next Entera Bio earnings date
Q4 202530 Mar, 2026
Entera Bio
Next Entera Bio earnings date
Q4 202530 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage